samedan logo
 
 
spacer
home > ebr > winter 2003 > the future of biomanufacturing
PUBLICATIONS
European Biopharmaceutical Review

The Future of Biomanufacturing

In my previous article, I reviewed the recent history of biopharmaceutical manufacturing, and the factors that have driven the industry to be the size and shape that it is today. In this article, I will be looking at the emerging trends and technologies, and considering the influence that they will have on biopharmaceutical manufacturing in the future.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Sharon Grimster, Director of Westerly Projects Ltd

Sharon Grimster started her career working on clinical trials at Guys Hospital Medical School in London. She then moved to Celltech, working in research for four years prior to taking up various management positions within contract manufacturing. Sharon subsequently managed preclinical and clinical development programmes for both new chemical entities and biological entities. Following the mergers with Chiroscience and Medeva, Sharon became Head of Biologics Manufacturing Development. She left Celltech in 2002 and is now a Director of Westerly Projects Ltd, a consultancy company offering development services to the biopharmaceutical industry globally.

spacer
Sharon Grimster
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

BIO-Europe

15-17 November 2010, Munich, Germany

The 16th annual BIO-Europe event will be the largest biotechnology partnering conference held in Europe. Over 2,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships.    
More info >>

 
News and Press Releases

Ready-Made Ammonium Formate Buffer Simplifies Glycoprofiling

To add to their range of drug glycoprofiling products, Ludger Ltd now offer the LudgerSep™ x40 ammonium formate buffer concentrate for glycan amide HPLC (Cat No. LS-N-BUFFX40). Preparation of ammonium formate buffer is laborious and variations in buffer pH between batches can result in out of specification problems during glycan analysis. The new x40 concentrate makes preparation of clean, consistent ammonium formate buffer easy - simply dilute with water and use directly for elution gradients for glycan HPLC.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement